Abstract

The Syriac Galen Palimpsest (SGP) is a remarkable manuscript that poses many challenges to scholars, yet also promises to yield much. Its undertext contains the Syriac translation by Sergius of R?? ?Ayn? of Galen?s On Simple Drugs. A team of scholars met at the University of Manchester to exploit the advances in imaging technology to study this palimpsest. Some initial results are presented here. SGP possibly contains the text of the whole second part of On Simple Drugs (i.e., Books VI?XI); to date, only Books VI?VIII had been thought to survive, as they are preserved in another famous manuscript, London, British Library, MS Add. 14661. SGP?s importance, however, does not merely lie in the fact that it preserves text not found elsewhere, but also in that it offers many important variant readings; it is therefore crucial for the textual history of Sergius? translation, as well as Galen?s On Simple Drugs more generally. Moveover, this Syriac translation also makes it possible to assess the role that Sergius played in the transmission of medical knowledge from Greek into Arabic. For the first time, one can compare the Greek source text of certain passages with the Syriac translations by Sergius and Hunayn, as well as the Arabic version by Hunayn. This initial comparison suggests that Hunayn is far more indebted to Sergius than he lets us believe in his Epistle (Ris?la); and that Sergius was a far more competent translator than previously thought.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.